Sangamo Therapeutics Inc
OTC:SGMOQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sangamo Therapeutics Inc
OTC:SGMOQ
|
US |
|
Docebo Inc
F:061
|
CA |
|
CRI Middleware Co Ltd
TSE:3698
|
JP |
|
G
|
Gantan Beauty Industry Co Ltd
TSE:5935
|
JP |
|
SanBio Co Ltd
OTC:SNBIF
|
JP |
|
Toyo Corp
F:TOY
|
JP |
|
T
|
Thrace Plastics Holding and Commercial SA
SWB:TP3
|
GR |
|
SuRo Capital Corp
F:0GV
|
US |
|
J
|
Jetway Information Co Ltd
TPEX:6161
|
TW |
|
K
|
KME Group SpA
SWB:MTJ3
|
IT |
|
Lifeist Wellness Inc
F:M5B0
|
CA |
|
T
|
Tao Heung Holdings Ltd
SWB:BVI
|
HK |
|
C
|
Companhia Energetica do Rio Grande do Norte Cosern
BOVESPA:CSRN6
|
BR |
Bankruptcy Probability
Sangamo Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sangamo Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Sangamo Therapeutics Inc
NASDAQ:SGMO
|
30.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
453.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sangamo Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sangamo Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
